$136.26
0.360.26%
Last update: Nov 10, 4:00 PM
Protagonist Therapeutics Inc
PTGXNASDAQ
The average analyst price target for Protagonist Therapeutics is $140.68, 3.2% above the current price. Of 17 analysts, 17 rate it Buy. Targets range from $38 to $221. The latest change came on Nov 6, 2026, when HC Wainwright & Co. raised its price target on Protagonist Therapeutics from $170 to $221 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 17 Analysts
Rating Trend — Last 9 Months
